Novocure Ltd (NASDAQ:NVCR)
| 73.53 Delayed Data As of 4:00pm ET |  -6.56 / -8.19%Today’s Change | 56.39 Today|||52-Week Range 94.00 | -2.06% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $8.4B |
Company Description
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Contact Information
NovoCure Ltd. No. 4 The Forum St. Helier Jersey JE2 4UF |
Employees
Shareholders
| Mutual fund holders | 56.70% |
| Individual stakeholders | 35.05% |
| Other institutional | 24.04% |
Top Executives
| Asaf Danziger | Chief Executive Officer & Director |
| Wilhelmus C. M. Groenhuysen | Chief Operating Officer |
| Ashley Cordova | Chief Financial Officer |
| Uri Weinberg | Chief Science Officer |
| Ely Benaim | Chief Medical Officer |
